Optimal molecular binding data and pharmacokinetic profiles of novel potential triple-action inhibitors of chymase, spleen tyrosine kinase, and prostaglandin D2 receptor in the treatment of asthma.
Precious Ayorinde AkinnusiSamuel Olawale OlubodeAyomide Oluwadarasimi AdebesinAdebowale Abiodun AladeVictor Chinedu NwokeSidiqat Adamson ShodehindePublished in: Journal, genetic engineering & biotechnology (2023)
These findings suggest that these compounds could be explored as triple-action inhibitors of the protein targets. They are, therefore, recommended for further analysis.